Cargando…

Synaptic Loss in Frontotemporal Dementia Revealed by [ (11)C]UCB‐J Positron Emission Tomography

OBJECTIVE: Synaptic loss is an early feature of neurodegenerative disease models, and is severe in post mortem clinical studies, including frontotemporal dementia. Positron emission tomography (PET) with radiotracers that bind to synaptic vesicle glycoprotein 2A enables quantification of synaptic de...

Descripción completa

Detalles Bibliográficos
Autores principales: Malpetti, Maura, Jones, P. Simon, Cope, Thomas E., Holland, Negin, Naessens, Michelle, Rouse, Matthew A., Rittman, Timothy, Savulich, George, Whiteside, David J., Street, Duncan, Fryer, Tim D., Hong, Young T., Milicevic Sephton, Selena, Aigbirhio, Franklin I., O′Brien, John T., Rowe, James B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099663/
https://www.ncbi.nlm.nih.gov/pubmed/36321699
http://dx.doi.org/10.1002/ana.26543
_version_ 1785025102348288000
author Malpetti, Maura
Jones, P. Simon
Cope, Thomas E.
Holland, Negin
Naessens, Michelle
Rouse, Matthew A.
Rittman, Timothy
Savulich, George
Whiteside, David J.
Street, Duncan
Fryer, Tim D.
Hong, Young T.
Milicevic Sephton, Selena
Aigbirhio, Franklin I.
O′Brien, John T.
Rowe, James B.
author_facet Malpetti, Maura
Jones, P. Simon
Cope, Thomas E.
Holland, Negin
Naessens, Michelle
Rouse, Matthew A.
Rittman, Timothy
Savulich, George
Whiteside, David J.
Street, Duncan
Fryer, Tim D.
Hong, Young T.
Milicevic Sephton, Selena
Aigbirhio, Franklin I.
O′Brien, John T.
Rowe, James B.
author_sort Malpetti, Maura
collection PubMed
description OBJECTIVE: Synaptic loss is an early feature of neurodegenerative disease models, and is severe in post mortem clinical studies, including frontotemporal dementia. Positron emission tomography (PET) with radiotracers that bind to synaptic vesicle glycoprotein 2A enables quantification of synaptic density in vivo. This study used [(11)C]UCB‐J PET in participants with behavioral variant frontotemporal dementia (bvFTD), testing the hypothesis that synaptic loss is severe and related to clinical severity. METHODS: Eleven participants with clinically probable bvFTD and 25 age‐ and sex‐matched healthy controls were included. Participants underwent dynamic [(11)C]UCB‐J PET, structural magnetic resonance imaging, and a neuropsychological battery, including the revised Addenbrooke Cognitive Examination, and INECO frontal screening. General linear models compared [(11)C]UCB‐J binding potential maps and gray matter volume between groups, and assessed associations between synaptic density and clinical severity in patients. Analyses were also performed using partial volume corrected [(11)C]UCB‐J binding potential from regions of interest (ROIs). RESULTS: Patients with bvFTD showed severe synaptic loss compared to controls. [(11)C]UCB‐J binding was reduced bilaterally in medial and dorsolateral frontal regions, inferior frontal gyri, anterior and posterior cingulate gyrus, insular cortex, and medial temporal lobe. Synaptic loss in the frontal and cingulate regions correlated significantly with cognitive impairments. Synaptic loss was more severe than atrophy. Results from ROI‐based analyses mirrored the voxelwise results. INTERPRETATION: In accordance with preclinical models, and human postmortem evidence, there is widespread frontotemporal loss of synapses in symptomatic bvFTD, in proportion to severity. [(11)C]UCB‐J PET could support translational studies and experimental medicine strategies for new disease‐modifying treatments for neurodegeneration. ANN NEUROL 2023;93:142–154
format Online
Article
Text
id pubmed-10099663
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-100996632023-04-14 Synaptic Loss in Frontotemporal Dementia Revealed by [ (11)C]UCB‐J Positron Emission Tomography Malpetti, Maura Jones, P. Simon Cope, Thomas E. Holland, Negin Naessens, Michelle Rouse, Matthew A. Rittman, Timothy Savulich, George Whiteside, David J. Street, Duncan Fryer, Tim D. Hong, Young T. Milicevic Sephton, Selena Aigbirhio, Franklin I. O′Brien, John T. Rowe, James B. Ann Neurol Research Articles OBJECTIVE: Synaptic loss is an early feature of neurodegenerative disease models, and is severe in post mortem clinical studies, including frontotemporal dementia. Positron emission tomography (PET) with radiotracers that bind to synaptic vesicle glycoprotein 2A enables quantification of synaptic density in vivo. This study used [(11)C]UCB‐J PET in participants with behavioral variant frontotemporal dementia (bvFTD), testing the hypothesis that synaptic loss is severe and related to clinical severity. METHODS: Eleven participants with clinically probable bvFTD and 25 age‐ and sex‐matched healthy controls were included. Participants underwent dynamic [(11)C]UCB‐J PET, structural magnetic resonance imaging, and a neuropsychological battery, including the revised Addenbrooke Cognitive Examination, and INECO frontal screening. General linear models compared [(11)C]UCB‐J binding potential maps and gray matter volume between groups, and assessed associations between synaptic density and clinical severity in patients. Analyses were also performed using partial volume corrected [(11)C]UCB‐J binding potential from regions of interest (ROIs). RESULTS: Patients with bvFTD showed severe synaptic loss compared to controls. [(11)C]UCB‐J binding was reduced bilaterally in medial and dorsolateral frontal regions, inferior frontal gyri, anterior and posterior cingulate gyrus, insular cortex, and medial temporal lobe. Synaptic loss in the frontal and cingulate regions correlated significantly with cognitive impairments. Synaptic loss was more severe than atrophy. Results from ROI‐based analyses mirrored the voxelwise results. INTERPRETATION: In accordance with preclinical models, and human postmortem evidence, there is widespread frontotemporal loss of synapses in symptomatic bvFTD, in proportion to severity. [(11)C]UCB‐J PET could support translational studies and experimental medicine strategies for new disease‐modifying treatments for neurodegeneration. ANN NEUROL 2023;93:142–154 John Wiley & Sons, Inc. 2022-11-16 2023-01 /pmc/articles/PMC10099663/ /pubmed/36321699 http://dx.doi.org/10.1002/ana.26543 Text en © 2022 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Malpetti, Maura
Jones, P. Simon
Cope, Thomas E.
Holland, Negin
Naessens, Michelle
Rouse, Matthew A.
Rittman, Timothy
Savulich, George
Whiteside, David J.
Street, Duncan
Fryer, Tim D.
Hong, Young T.
Milicevic Sephton, Selena
Aigbirhio, Franklin I.
O′Brien, John T.
Rowe, James B.
Synaptic Loss in Frontotemporal Dementia Revealed by [ (11)C]UCB‐J Positron Emission Tomography
title Synaptic Loss in Frontotemporal Dementia Revealed by [ (11)C]UCB‐J Positron Emission Tomography
title_full Synaptic Loss in Frontotemporal Dementia Revealed by [ (11)C]UCB‐J Positron Emission Tomography
title_fullStr Synaptic Loss in Frontotemporal Dementia Revealed by [ (11)C]UCB‐J Positron Emission Tomography
title_full_unstemmed Synaptic Loss in Frontotemporal Dementia Revealed by [ (11)C]UCB‐J Positron Emission Tomography
title_short Synaptic Loss in Frontotemporal Dementia Revealed by [ (11)C]UCB‐J Positron Emission Tomography
title_sort synaptic loss in frontotemporal dementia revealed by [ (11)c]ucb‐j positron emission tomography
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099663/
https://www.ncbi.nlm.nih.gov/pubmed/36321699
http://dx.doi.org/10.1002/ana.26543
work_keys_str_mv AT malpettimaura synapticlossinfrontotemporaldementiarevealedby11cucbjpositronemissiontomography
AT jonespsimon synapticlossinfrontotemporaldementiarevealedby11cucbjpositronemissiontomography
AT copethomase synapticlossinfrontotemporaldementiarevealedby11cucbjpositronemissiontomography
AT hollandnegin synapticlossinfrontotemporaldementiarevealedby11cucbjpositronemissiontomography
AT naessensmichelle synapticlossinfrontotemporaldementiarevealedby11cucbjpositronemissiontomography
AT rousematthewa synapticlossinfrontotemporaldementiarevealedby11cucbjpositronemissiontomography
AT rittmantimothy synapticlossinfrontotemporaldementiarevealedby11cucbjpositronemissiontomography
AT savulichgeorge synapticlossinfrontotemporaldementiarevealedby11cucbjpositronemissiontomography
AT whitesidedavidj synapticlossinfrontotemporaldementiarevealedby11cucbjpositronemissiontomography
AT streetduncan synapticlossinfrontotemporaldementiarevealedby11cucbjpositronemissiontomography
AT fryertimd synapticlossinfrontotemporaldementiarevealedby11cucbjpositronemissiontomography
AT hongyoungt synapticlossinfrontotemporaldementiarevealedby11cucbjpositronemissiontomography
AT milicevicsephtonselena synapticlossinfrontotemporaldementiarevealedby11cucbjpositronemissiontomography
AT aigbirhiofranklini synapticlossinfrontotemporaldementiarevealedby11cucbjpositronemissiontomography
AT obrienjohnt synapticlossinfrontotemporaldementiarevealedby11cucbjpositronemissiontomography
AT rowejamesb synapticlossinfrontotemporaldementiarevealedby11cucbjpositronemissiontomography